Epanutin 30mg/5ml oral suspension out of stock until late June 2020
We have been informed by Pfizer that there will be insufficient stocks of Epanutin 30mg/5ml oral suspension, from the week commencing 2 March 2020. This supply issue is expected to last until late June 2020.
During this period, Pfizer has been able to import sufficient supplies of the Canadian product, Dilantin-30 to fill the gap.
Epanutin (phenytoin) is a category 1 anti-epileptic medication. Anyone who is switched to Dilantin-30 should be carefully monitored and may require specialist advice or support.
If you are taking Epanutin, make sure you discuss your prescription with your doctor.
Call our Helpline
If you are taking Epanutin 30mg/5ml oral suspension and are feeling anxious about this change, please call our Helpline on 01494 601400 (Mon and Tues 9am-4pm and Wed 9am-7.30pm).